LU90118B1 - Use of melatonin in the treatment of patients with addiction to certain drugs - Google Patents
Use of melatonin in the treatment of patients with addiction to certain drugs Download PDFInfo
- Publication number
- LU90118B1 LU90118B1 LU90118A LU90118A LU90118B1 LU 90118 B1 LU90118 B1 LU 90118B1 LU 90118 A LU90118 A LU 90118A LU 90118 A LU90118 A LU 90118A LU 90118 B1 LU90118 B1 LU 90118B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- melatonin
- addiction
- patients
- treatment
- certain drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
PCT/IB1996/000082 WO1996023496A1 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treating patients suffering from drug addiction |
Publications (1)
Publication Number | Publication Date |
---|---|
LU90118B1 true LU90118B1 (en) | 1997-11-13 |
Family
ID=26140195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU90118A LU90118B1 (en) | 1995-02-01 | 1997-08-01 | Use of melatonin in the treatment of patients with addiction to certain drugs |
Country Status (22)
Country | Link |
---|---|
JP (1) | JP4516159B2 (en) |
CN (1) | CN1083263C (en) |
AT (1) | AT408188B (en) |
AU (1) | AU695366B2 (en) |
BG (1) | BG62876B1 (en) |
BR (1) | BR9607169A (en) |
CZ (1) | CZ291349B6 (en) |
DK (1) | DK176081B1 (en) |
EE (1) | EE03384B1 (en) |
FI (1) | FI119586B (en) |
IS (1) | IS1980B (en) |
LU (1) | LU90118B1 (en) |
LV (1) | LV11940B (en) |
MD (1) | MD1716C2 (en) |
NO (1) | NO312814B1 (en) |
NZ (1) | NZ298878A (en) |
PL (1) | PL183148B1 (en) |
SI (1) | SI9620022A (en) |
SK (1) | SK284521B6 (en) |
TR (1) | TR199700723T1 (en) |
TW (1) | TW483757B (en) |
WO (1) | WO1996023496A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK287508B6 (en) | 2000-01-05 | 2010-12-07 | Neurim Pharmaceuticals (1991) Ltd. | Use and formulation for treating resistance to antihypertensives and related conditions |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Composition for treating insomnia |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
KR20180100450A (en) | 2012-01-26 | 2018-09-10 | 반다 파마슈티칼즈, 인코퍼레이티드. | Treatment of circadian rhythm disorders |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
KR102148990B1 (en) | 2012-12-18 | 2020-08-27 | 반다 파마슈티칼즈, 인코퍼레이티드. | Treatment of circadian rhythm disorders |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
SI3337462T1 (en) * | 2016-10-31 | 2021-01-29 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0518468B1 (en) * | 1991-05-09 | 1999-06-30 | Neurim Pharmaceuticals (1991) Limited | Melatonin containing compositions |
IT1251544B (en) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE |
-
1996
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en active IP Right Grant
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2007001I2 (en) | MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES | |
IT9083334A0 (en) | PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA | |
DE69332952D1 (en) | Biocompatible polymers containing diagnostic and therapeutic units | |
FI94028B (en) | Device for the diagnosis and treatment of nasal diseases | |
EE03512B1 (en) | Epinastine for use in the treatment of pain | |
HUP0104803A3 (en) | Process and system for the administration of medicine through the skin | |
LU90118B1 (en) | Use of melatonin in the treatment of patients with addiction to certain drugs | |
HK1001375A1 (en) | Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries | |
FR2717080B1 (en) | Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases. | |
KR960702315A (en) | Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage | |
FR2684552B1 (en) | USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS. | |
FR2792199B3 (en) | USE OF OSANETANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF MOOD DISORDERS | |
NO960545D0 (en) | Treatment of adverse effects associated with the administration of extracellular hemoglobin | |
FR2774596B1 (en) | USE OF SELENATED COMPOUNDS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE | |
FR2722989B1 (en) | USE OF IFENPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES AND CENTRAL NEURODEGENERATIVE DISEASES | |
ZA9610584B (en) | Use of rc-9 in diagnosis and treatment of proliferative arterial disease | |
FR2744364B1 (en) | APPLICATION OF UREIDOACETAMIDES TO THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE | |
GB9401745D0 (en) | Improvements in and relating to the administration of medicaments or therapeutic substances | |
AU8195091A (en) | Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease | |
FR2702151B1 (en) | Application of anti-convulsants in the treatment of neuro-AIDS. | |
GB9701919D0 (en) | Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1 | |
FR2758980B1 (en) | LOCAL AND GENERAL BODY TREATMENT HYDROTHERAPY APPARATUS | |
FR2744363B1 (en) | APPLICATION OF THIAZOLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIA OR EXCESSIVE USE | |
ID28817A (en) | USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT | |
FR2727864B1 (en) | USE OF LIGANDS FROM THE PERIPHERAL BINDING SITES FOR BENZODIAZEPINES FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES |